By Rebecca Melvin
New York, Sept. 25 – Lannett Co. Inc. priced $75 million of 4.5% seven-year convertible senior notes, with a 10% initial conversion premium, according to a company news release on Wednesday.
There is a greenshoe of $11.25 million for the Rule 144A deal, which was sold by bookrunner Credit Suisse Securities (USA) LLC.
The notes are non-callable for four years and then provisionally callable at a price trigger of 130%. They will be settled in shares at maturity.
In connection with the pricing of the notes, the company entered into a capped call transaction with an affiliate of the initial purchaser of the notes. The strike on the capped call is $19.46, which represents a premium of about 40% from the issuer’s perspective.
The proceeds of the offering will be used to reduce outstanding borrowings under the company’s existing term loan A under its existing senior credit facility and to pay the cost of the capped call transaction.
Lannett is a generic drug company based in Philadelphia.
Issuer: | Lannett Co. Inc.
|
Securities: | Convertible senior notes
|
Amount: | $75 million
|
Greenshoe: | $11.25 million
|
Maturity: | Oct. 1, 2026
|
Bookrunner: | Credit Suisse Securities (USA) LLC
|
Coupon: | 4.5%
|
Conversion premium: | 10%
|
Conversion price: | $15.29
|
Conversion rate: | 65.4022
|
Call options: | Non-callable until Oct. 6, 2023, then provisionally callable at 130% price hurdle
|
Capped call: | Yes, at $19.46 strike
|
Pricing date: | Sept. 25
|
Settlement date: | Sept. 27
|
Distribution: | Rule 144A
|
Stock symbol: | NYSE: LCI
|
Stock price: | $13.90 at market close Sept. 24
|
Market capitalization: | $469.92 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.